FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4511211000001109: Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17785101000001110 Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17785201000001115 Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Is a Product containing precisely razoxane 125 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient Cytoprotective agent false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient Substance with chelating agent mechanism of action false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient Antidote false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has active ingredient Razoxane false Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient Razoxane true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) 30 tablet Is pack of False Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) 30 tablet Has AMP True Razoxane 125mg tablets (A A H Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start